Manufacturer record
Dr. Puri Proprietory Product: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Dr. Puri Proprietory Product were declared Not of Standard Quality between July 2026 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
1 record linked to Dr. Puri Proprietory Product in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diabetis-All Powder | A-1Mfg 2025-07 · Exp 2030-07 | The Sample gives TLC and HPLC [dentification Test for the Presence of Pioglitazone Hydrochloride. lFound Content of Pioglitazone Hydrochloride: 0.32mg/gm. The Sample is declared as Spurious Vide Section 33-EEA(d) of Drugs And Cosmetics Act 1940 and Rules thereunder.Spurious | FDAL, Chhatrapati SambhajinagarState lab | Jul 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.